Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carmen Giacomuzzi is active.

Publication


Featured researches published by Carmen Giacomuzzi.


The Annals of Thoracic Surgery | 2004

Routine mechanical ventricular assist following the Norwood procedure—improved neurologic outcome and excellent hospital survival

Ross M. Ungerleider; Irving Shen; Thomas Yeh; Jess M. Schultz; Robert W. Butler; Michael Silberbach; Carmen Giacomuzzi; Eileen Heller; Leanne Studenberg; Brian Mejak; Jamie You; Debbie Farrel; Scott McClure; Erle H. Austin

BACKGROUND Although excellent survival following the Norwood procedure for palliation of hypoplastic left heart syndrome (HLHS) is being achieved by some, most centers, especially the ones with small surgical volume and limited experience, continue to struggle with initial results. Survivors often showed evidence of significant neurologic injury. The early postoperative care is labor-intensive as attempts are made to balance the systemic and pulmonary circulation for these infants. We report our experience with routine use of mechanical circulatory assist to support the increased cardiac output requirements present following Norwood procedure. METHODS Eighteen consecutive infants undergoing Norwood operation for HLHS (Oregon Health & Science University [OHSU] 13; University of Louisville [UL] 5) were placed on a ventricular assist device (VAD) immediately following modified ultrafiltration in the operating room using the cardiopulmonary bypass (CPB) cannulas that were in the right atrium and the neoaorta. VAD flows were maintained at approximately 200 mL x kg(-1) x min(-1) and the patients were transported to the intensive care unit (ICU). Patients operated at OHSU also received neurodevelopmental testing before their Glenn procedure, approximately 4 to 6 months following their Norwood operation. RESULTS All patients were stable on VAD support and no attempt was made to balance the systemic and pulmonary circulation. The ventilator was manipulated to achieve systemic Pa0(2) between 30 and 45 mm Hg and PaC0(2) between 35 and 45 mm Hg. Evidence of hypoperfusion (increasing lactates) was managed by increasing the VAD flow. Lactates normalized [< 2 mmol/L]) by 1.8 +/- 1.1 days following surgery. Average time of VAD support was 3.1 +/- 1.0 (range, 2 to 5 days) and average time until chest closure was 3.4 +/- 1.5 (range, 2 to 8 days). There were two cases of postoperative bleeding (11.1%) requiring reexploration and one case of mediastinitis (5.5%) in a patient who has now gone on to successful Glenn. Sixteen of the eighteen patients survived (hospital survival mean 89% with a 95% confidence interval of 63.9% to 98.1%; 12/13 OHSU [92.3%]; 4/5 UL [80%]). Neurodevelopmental testing using the Mullen Scales of Early Learning and the Vineland Adaptive Behavior Scale were normal for all infants tested. CONCLUSIONS Routine postoperative use of VAD can support the increased cardiac output demands of infants following Norwood operation and results in a stable postoperative convalescence that does not require aggressive ventilator or inotrope manipulation. Although not a panacea, this strategy can simplify postoperative management, lead to excellent hospital survival, and possibly augment cerebral oxygen delivery, resulting in improved neurologic outcomes for this challenging group of patients.


The Annals of Thoracic Surgery | 2003

Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants

Irving Shen; Carmen Giacomuzzi; Ross M. Ungerleider

The use of cardiopulmonary bypass is still necessary for the repair of many congenital cardiac defects. However, exposure to cardiopulmonary bypass can still lead to major morbidity and sometimes mortality, especially in neonates and infants, despite a perfect surgical repair. Various research-based strategies have been used to minimize some of the complications related to cardiopulmonary bypass, including the systemic inflammatory response, hemodilution, and transfusion requirement. This overview provides some of the strategies that we use in our practice in applying cardiopulmonary bypass in the repair of congenital cardiac defects in neonates and infants.


Cardiology in The Young | 2008

Complications relating to perfusion and extracorporeal circulation associated with the treatment of patients with congenital cardiac disease: Consensus Definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease

Kenneth G. Shann; Carmen Giacomuzzi; Lynn Harness; Gerard J. Myers; Theron A. Paugh; Nicholas B. Mellas; Robert C. Groom; Daniel Gomez; Clarke A. Thuys; Kevin Charette; Jorge W. Ojito; Julie Tinius-Juliani; Christos Calaritis; Craig M. McRobb; Michael Parpard; Tom Chancy; Emile A. Bacha; David S. Cooper; Jeffrey P. Jacobs; Donald S. Likosky

The International Consortium for Evidence-Based Perfusion (www.bestpracticeperfusion.org) is a collaborative partnership of societies of perfusionists, professional medical societies, and interested clinicians, whose aim is to promote the continuous improvement of the delivery of care and outcomes for patients undergoing extracorporeal circulation. Despite the many advances made throughout the history of cardiopulmonary bypass, significant variation in practice and potential for complication remains. To help address this issue, the International Consortium for Evidence-Based Perfusion has joined the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease to develop a list of complications in congenital cardiac surgery related to extracorporeal circulation conducted via cardiopulmonary bypass, extracorporeal membrane oxygenation, or mechanical circulatory support devices, which include ventricular assist devices and intra-aortic balloon pumps. Understanding and defining the complications that may occur related to extracorporeal circulation in congenital patients is requisite for assessing and subsequently improving the care provided to the patients we serve. The aim of this manuscript is to identify and define the myriad of complications directly related to the extracorporeal circulation of congenital patients.


World Journal for Pediatric and Congenital Heart Surgery | 2010

Rationale and use of perfusion variables in the 2010 update of the society of thoracic surgeons congenital heart surgery database.

Kenneth G. Shann; Carmen Giacomuzzi; Jeffrey P. Jacobs; Gerard J. Myers; Theron A. Paugh; Nicholas B. Mellas; Luc Puis; Jorge W. Ojito; Daniel Gomez; Vincent Olshove; David Fitzgerald; Hideshi Itoh; Christopher P. Brabant; Clarke A. Thuys; Kevin Charette; Christos Calaritis; Michael Parpard; Tom Chancy; Robert A. Baker; Kamal K. Pourmoghadam; Donald S. Likosky

Patients undergoing congenital heart surgery are at risk of morbidity and mortality. The reasons underlying this risk are complex. To identify opportunities to reduce adverse sequelae, the cardiovascular perfusion community was invited to amend existing perfusion-related fields as well as add new ones to the current version of the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD). The International Consortium for Evidence-Based Perfusion (ICEBP) was invited by the STS-CHSD Task Force to identify and resolve ambiguities related to definitions among the 3 current perfusion-related fields as well as to propose new variables (and definitions) for inclusion in the 2010 update of the STS-CHSD. The ICEBP used teleconferences, wiki-based communication software, and e-mail to discuss current definitions and create new fields with definitions. The ICEBP created modified definitions to existing fields related to cardiovascular perfusion and also developed and defined new fields that focus on (1) techniques of circulatory arrest and cerebral perfusion, (2) strategies of myocardial protection, and (3) techniques to minimize hemodilution and allogeneic blood transfusions. Three fields in the STS-CHSD related to perfusion were redefined, and 23 new variables and definitions were selected for inclusion. Identifying and defining fields specific to the practice of perfusion are requisite for assessing and subsequently improving the care provided to patients undergoing congenital heart surgery. The article describes the methods and justification for adjudicating extant and new perfusion-related fields added to the 2010 update of the STS-CHSD.


Asaio Journal | 2008

Fourth International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion.

Akif Ündar; Ross M. Ungerleider; Carmen Giacomuzzi; Brian W. Duncan; Gerson Rosenberg; William S. Pierce; John A. Waldhausen; John L. Myers

The Fourth International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion was held at the Hilton Portland and Executive Tower, Portland, Oregon, May 22–24, 2008. Over 250 participants from 17 countries including Australia, Austria, Canada, China, France, Germany, Italy, Japan, Netherlands, New Zealand, Philippines, Saudi Arabia, South Korea, Sweden, Turkey, the United Kingdom, and the United States attended this unique event. With the Fourth Annual Event, we continued to focus on the objective of our previous conferences, that is, to explicitly describe the problems with current pediatric mechanical circulatory support systems, methods, and techniques during acute and chronic support and to suggest solutions.1 Of the 101 slide and poster presentations at this event, 48 were invited lectures by leading scholars from around the globe on selected topics. The Conference Proceedings with details of the final scientific program, as well as all abstracts from slide and poster presenters and invited lecturers, are now available on the conference web site http://www.ohsu.edu/CPBConference.


The Annals of Thoracic Surgery | 2005

Extracorporeal Life Support in Neonates, Infants, and Children After Repair of Congenital Heart Disease: Modern Era Results in a Single Institution

Bahaaldin Alsoufi; Irving Shen; Tara Karamlou; Carmen Giacomuzzi; Grant H. Burch; Michael Silberbach; Ross M. Ungerleider


The journal of extra-corporeal technology | 2004

Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.

Brian Mejak; Carmen Giacomuzzi; Eileen Heller; Xiaomang You; Ross M. Ungerleider; Irving Shen; Lynn K. Boshkov


The journal of extra-corporeal technology | 2005

Cardiopulmonary Bypass Using Argatroban as an Anticoagulant for a 6.0-kg Pediatric Patient

Brian Mejak; Carmen Giacomuzzi; Irving Shen; Lynn K. Boshkov; Ross M. Ungerleider


Cardiology in The Young | 2005

Assessing the brain using near-infrared spectroscopy during postoperative ventricular circulatory support.

Carmen Giacomuzzi; Eileen Heller; Brian Mejak; Jamie You; Ross M. Ungerleider; Michael Silberbach


Archive | 2012

Pediatric cardiopulmonary bypass overview: State of the art and future

Carmen Giacomuzzi; Brian Mejak; Irving Shen

Collaboration


Dive into the Carmen Giacomuzzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Gomez

Nationwide Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge